Abstract:The purpose of this work was to compare the clinical characteristics, rate of recurrent venous thromboembolism (VTE), bleeding complications and mortality of incidental and symptomatic pulmonary embolism (PE) detected on computed tomography in patients with lung cancer. Clinical data of lung cancer patients with PE were obtained from the Department of Respiratory and Critical Care Medicine of Ningbo First affiliated hospital of Ningbo University during January 2016 and June 2021 and were reviewed retrospectively. We compared clinical and radiological characteristics in lung cancer patients with incidental PE (IPE) and symptomatic PE (SPE) and identified variables associated with the 1-year survival on multivariate Cox analysis. All patients were followed up for 1 year to compare the risks of recurrent VTE, bleeding complications, and mortality. Survival analysis was performed by use of Kaplan-Meier. A total of 223 lung cancer patients with PE were enrolled over the period. Of these, 117 (52%) patients had symptomatic whereas 106 (48%) patients had incidental PE. Those with IPE were more likely to have adenocarcinoma, VTE history, chronic respiratory disease and chemotherapy within 30 days prior to PE, while SPE was more frequently observed in patients with squamous cancer, concomitant VTE, performance status 0-1, chronic heart disease and major surgery within 30 days prior to PE. During 1 year of follow-up, recurrent VTE was diagnosed in 10 patients (9.3%) in lung cancer patients with IPE and 13 patients (11.2%) with SPE. The 12-month cumulative recurrent VTE incidence was 9.6% for patients with incidental and 11.4% for patients with symptomatic PE (P = .61). The 12-month cumulative incidences of major bleeding complications were also comparable in the 2 groups (8.1% for incidental patients and 9.8% for symptomatic patients; P = .62). However, the respective 12-month mortality risks were 34.6% and 30.2% in lung cancer patients with IPE and SPE respectively (P = .03). On multivariate Cox analysis, we found that IPE occurrence was an independent risk factor associated with 1-year mortality in lung cancer patients complicated with PE after adjusting for age and sex (HR 1.517; 95% CI: 1.366-1.684; P = .027). Our findings suggest that lung cancer patients diagnosed with and treated for incidental PE had a similar rate of recurrent VTE, and incidence of hemorrhagic complications, but a significantly higher 1-year cumulative mortality rate after PE compared to those with symptomatic PE. IPE may be a marker of poor prognosis.

Role of SCA2 mutations in early‐ and late‐onset dopa‐responsive parkinsonism

Incidentally Diagnosed with Pulmonary Embolism in Lung Cancer Patients: Comparison of Clinical Characteristics and Mortality with Symptomatic Pulmonary Embolism

Radiological Features of Primary Pulmonary Non-Hodgkin Lymphoma: Report of Three Cases

Role of Transthoracic Lung Ultrasonography in the Diagnosis of Pulmonary Embolism: A Systematic Review and Meta-Analysis

An association study of asthma and total serum immunoglobin E levels for Toll‐like receptor polymorphisms in a Japanese population

Occurrence of cathepsin D isozymes with different specificities in monkey skeletal muscle.

Not Just CTEPH: A Narrative Review on the Spectrum Approach to Postpulmonary Embolism Conditions

Transcatheter Aspiration Utilizing Inari Flowtriever® System Leads To Diagnosis Of Pulmonary Artery Tumor Embolism Masquerading As Saddle Pulmonary Thromboembolism

Primary pulmonary extranodal natural killer/T-cell lymphoma (ENKTL), nasal type: Two case reports and literature review

Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients

Physician-hospital partnering: medical clinic foundations, practice acquisitions, mergers, and MSOs.

The rare of the rarest: PSTT, ETT, APSN

Industrial bioconversion of renewable resources as an alternative to conventional chemistry

Colors of transparent submicron suspensions on approaching the Rayleigh regime.

Pulmonary embolism in patients with cancer: An updated and operative guide for diagnosis and management

Non-pyothorax-associated Primary Pleural Lymphoma Without Pleural Effusion in an Immunocompetent Patient: a Case Report and Literature Review.

Recurrent metastatic breast cancer manifesting as pulmonary tumor thrombotic microangiopathy with interstitial pulmonary fibrosis and infarcts: A clinicopathological correlation

Use of Ultrasound-Assisted, Catheter-Directed Thrombolysis in a Patient With High-Risk Pulmonary Embolism

Transarterial embolization for the management of emergent hemoptysis in patients with primary and metastatic lung tumors

Primary Pulmonary Hodgkin's Lymphoma Revealed by a Cavitary Lung Lesion: A Case With an Atypical Presentation and Literature Review

Chronic thromboembolic pulmonary disease